Nuclear Medicine Radioisotopes Market Boosted by Precision Imaging and Rising Cancer Diagnoses | NTP Radioisotopes SOC Ltd, Nordion Inc.

Nuclear Medicine Radioisotopes Market is projected to reach a high CAGR 12.8% during the forecast period (2024-2031).

Nuclear Medicine Radioisotopes Market Report by DataM Intelligence offers a detailed assessment of the global pharmaceutical and healthcare landscape, highlighting market size, key players, and critical growth drivers. With expanding use in oncology, cardiology, and neurology diagnostics, along with rising demand for theranostics, the report delivers strategic insights to support stakeholders in the radiopharmaceuticals market from 2025 to 2033.

Download exclusive insights with our detailed sample report (Corporate Email ID gets priority access): https://www.datamintelligence.com/download-sample/nuclear-medicine-radioisotopes-market?ophp

This market involves radioactive isotopes used in diagnostics (like PET and SPECT) and therapeutic procedures. Increasing cancer and cardiovascular disease rates, coupled with a demand for early diagnosis, are boosting the market. Key isotopes include technetium-99m and iodine-131, while theranostics and alpha-emitters offer new growth frontiers.

Nuclear Medicine Radioisotopes Market Competitors Overview:

NTP Radioisotopes SOC Ltd, Nordion Inc., (Sotera Health company), Cardinal Health, Inc, Bayer AG, GE Company (GE Healthcare) and NorthStar Medical Radioisotopes, LLC.

Important Industry Updates of 2023, 2024 and 2025:

✅ March 2025 - The FDA expanded the label for Pluvicto® (Lu‐PSMA‐617) to include use after androgen receptor inhibitors, optimizing its role in metastatic castration-resistant prostate cancer management

✅ September 2024 / rollout in 2025 - The FDA approved Flurpiridaz F‐18 (Flyrcado), a PET myocardial perfusion imaging tracer, enabling stress imaging with improved workflow and accuracy

✅ Eli Lilly invested $10 million into Ionetix-a cyclotron-powered Actinium-225 (^225Ac) producer-to secure access to this scarce alpha-emitting isotope critical for emerging cancer radiopharmaceuticals.

✅ German CDMO ROTOP Pharmaka received a strategic backing from GENUI and SHS Capital to scale up production of ready-to-use doses for radioligand therapy (RLT) in 2025

Methodology and Scope

The Nuclear Medicine Radioisotopes Market Report is built on a rigorous research methodology that integrates primary interviews, expert insights, and validated secondary data from company reports, industry publications, and reliable databases. Utilizing both bottom-up and top-down approaches, the analysis ensures high data accuracy through triangulation. The report covers current market dynamics, growth opportunities, and key strategic developments across global and regional markets.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/nuclear-medicine-radioisotopes-market?ophp

Nuclear Medicine Radioisotopes Market Segments Overview:

∎ By Type of Radioisotopes (Fluorine-18, Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Iodine (I-123), Rubidium-82 (Rb-82), Iodine-131 (I-131), Lutetium-177 (Lu-177), Radium-223 (Ra-223) and Alpharadin, Actinium-225 (Ac-225), Other Types of Radioisotopes)
∎ By Application (Cardiology, Oncology, Thyroid, Neurology, Other Applications)
∎ By End-User (Hospitals, Diagnostic centers, Specialty Clinics, Education and Research institutes, Others)

The diagnostic radioisotopes segment, particularly technetium-99m, accounts for the largest share due to its widespread use in imaging procedures such as SPECT for cardiology and oncology.

Regional Overview for Nuclear Medicine Radioisotopes Market:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

North America leads due to robust PET/CT infrastructure and SPECT usage. Asia Pacific is the fastest growing with increasing adoption of molecular imaging and government investment.

Looking for in-depth insights? Grab the full report: https://www.datamintelligence.com/buy-now-page?report=nuclear-medicine-radioisotopes-market?ophp

The Report Covers:

➡ In-depth analysis of the demand-supply gap, market size estimates, SWOT and PESTEL analysis, along with global market forecasts.
➡ Strategic recommendations with a focused go-to-market approach.
➡ An unbiased evaluation of overall market performance.
➡ Region- and country-specific insights, with customized reports available upon request.
➡ Identification of high-potential and niche segments and regions demonstrating strong growth prospects.

People Also Ask:

➤ What are the current global trends in sales, production, imports, and exports within the Nuclear Medicine Radioisotopes market?
➤ Who are the leading manufacturers, and what are their production volumes, pricing strategies, and revenue metrics?
➤ What are the major opportunities and challenges facing vendors in this market?
➤ Which product categories, applications, or end-user segments are contributing most to market growth and share?
➤ What are the primary factors driving and restraining growth in the Nuclear Medicine Radioisotopes market?

Unlock 360° Market Intelligence with 2 Days FREE Trial Access of DataM Subscription Now!: https://www.datamintelligence.com/reports-subscription?ophp

✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Pipeline Analysis For Drugs Discovery
✅ Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Competitive Landscape

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.